Roy Bloom, MD
As an AST member for over 20 years, I have enthusiastically served the society in many capacities that have helped to contribute to its ongoing growth and success. This has encompassed service on several AST committees including the Patient Care and Education Committee, the Pancreas Transplant Committee, the Clinical Trials Advisory Council as well as the Education Committee. My strong commitment to the educational mission of the AST is underscored by having served as co-chair of the AST/ASN Kidney Transplant Process Improvement Module for the ABIM Maintenance of Certification, co-chair of the AST/ASN Annual Transplant Nephrology Course at Kidney Week, member of the AST Fellows Symposium Core Curriculum Workgroup, as well as an ongoing member of the AST/ASN Transplant Nephrology Core Curriculum Committee.
I have additionally actively served as an invited member for many important societal initiatives including the AST Clinical Trials Symposium, the AST Consensus Conference on Non-Adherence Issues in Transplant Patients, the AST Hepatitis B Consensus Workgroup, the AST/ASTS Combined Kidney/Liver Consensus Conference, the AST/ASTS Workshop to Explore Incentives for Increasing Organ Donation as well as the recent AST Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation. Finally, I currently serve on the Program Committee of the AST Cutting Edge of Transplantation annual meeting that has seen a resurgence in recent years.
Outside of my commitment to the AST, I have served the American Society of Nephrology as a member of its Transplant Advisory Group, as a transplant representative on its Postgraduate Education Committee, and as a transplant representative on its Public Policy Board. I have also recently completed service on the OPTN/UNOS Ad Hoc International Relations Committee. On an international level, I have served on workgroups for KDIGO (Kidney Diseases Improving Global Outcomes) related to the development of clinical practice guidelines for kidney transplant recipients, as well as for managing hepatitis C in kidney transplantation.